GOUT Wayne Blount, MD, MPH Professor, Emory Univ. S.O.M.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Little Rheumatology gems for GP Trainees HDR 7/12/10 Hayley Faries, ST1 Rheumatology.
Team Meeting Presentations
1. Describe the pathogenesis of hyperuricemia and gout Goup C1 Group C1.
Rheumatoid arthritis in adults
TXF Caveat on urate levels Serum uric acid level may be normal at the time of an acute attack. Normal level does not rule out gout. May be better.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
GOUT AND PSEUDOGOUT ANDRES QUICENO, MD Rheumatology Division
{ Gout and Bursitis Asfand Baig.   Inflammatory arthritis associated with hyperuricaemia* and intra-articular sodium urate crystals Gout.
Purine Degradation & Gout (Musculoskeletal Block)
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Gout.
Gout : Clinical review and trial design issues Joel Schiffenbauer FDA/DAAODP AAC/June 3, 2004.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
Gout: Its not all crystal clear Robert L. Wortmann, M.D. Department of Internal Medicine The University of Oklahoma College of Medicine, Tulsa.
1 Uric acid and Gout James Witter MD, PhD Arthritis Advisory Meeting June 2, 2004.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Purine degradation & Gout (Musculoskeletal Block).
Gout Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Uric acid xiaoli.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
Purine Degradation & Gout (Musculoskeletal Block)
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Gout By Shravya & Helen. Gout is… An inflammatory arthritis associated with hyperuricaemia and intra-articular sodium urate crystals.
Uric Acid Metabolism & Gout
HYPERURICEMIA and GOUT PATHOGENESIS. HYPERURICEMIA Plasma/serum urate concentration >408 mol/L (6.8 mg/dL) Present in between 2.0 and 13.2% of ambulatory.
GOUT. Definition Heterogeneous group of diseases involving : An elevated serum urate concentration (hyperuricemia) Recurrent attacks of acute arthritis.
Diagnosis of gout.
Gout extra Q’s. After giving Marilyn analgesia you arrange an ultrasound and guided aspiration of Marilyn's first metatarsophalangeal joint. The initial.
GOUT TREATMENT. Gout prevalence doubled over the last 20 yrs. Factors? - longevity - diuretic use - low dose ASA - obesity - end stage renal disease -
HPI A 52 yo male presents to his PCP on a Monday morning with exquisite right knee pain that started overnight. He spent Sunday tailgating with friends.
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Drug Therapy of Gout. Drug therapy of gout What Is Gout?
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Metabolic Diseases of the Bone
Angelo L Gaffo Kenneth G Saag Core Evidence 2009:4 25–36
PA Days Presentation Brian K. Shrawder, PA-S LHU.
Dr. Müge Bıçakçıgil Kalaycı
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
Gout is a species-wide inborn error of purine metabolism D. Branch Moody, M.D. Professor of Medicine Immunology Laboratory, Smith Building
Gout -revisited Shrenik Shah. definition Monosodium urate (MSU) crystal deposition  episodic and later persistent joint inflammation and tophi All MSU.
Gout and Pseudogout dr. MUH. ARDI MUNIR, M.Kes., Sp.OT., M.H., FICS.
Colchicine: Colchicine: Effective & specific gout Rx, but less favored than NSAIDs because of slow onset of action & high incidence of side effects. Effective.
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 165 (1): ITC1-1. In the Clinic Gout.
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
GOUT Katie Margelot NURS 870. Definition Gout is an acute, sudden inflammatory disease of the joint, caused by high concentrations of uric acid in the.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Gout Disease of Kings Dr.Fakhir Yousif.
Crystalopathies Joanna Zalewska.
Gout Asad Khan Consultant Rheumatologist
Gout.
Introduction to pathology
Drug Therapy of Gout 1.
RUINS IN POMPEI, ITALY. RUINS IN POMPEI, ITALY.
Antiuricaemic drugs Dr A.W Olusanya.
GOUT By: Sunit tolia, PGY III.
Lecture 9 Musculoskeletal Disorders Gout
Scott Vogelgesang, M.D. Division of Immunology: Rheumatology & Allergy
Gout Scott Smith PGY-1 1/11/2018.
Purine Degradation & Gout (Musculoskeletal Block)
Purine Degradation & Gout (Musculoskeletal Block)
Presentation transcript:

GOUT Wayne Blount, MD, MPH Professor, Emory Univ. S.O.M.

OBJECTIVES Identify diagnostic criteria for gout Identify diagnostic criteria for gout Identify 3 treatment goals for gout Identify 3 treatment goals for gout Name the agents used to treat the acute flares of gout and the chronic disease of gout Name the agents used to treat the acute flares of gout and the chronic disease of gout

Why Worry About Gout ? Prevalence increasing Prevalence increasing May be signal for unrecognized comorbidities : ( Not to point of searching) May be signal for unrecognized comorbidities : ( Not to point of searching) Obesity (Duh!) Metabolic syndrome DMHTN CV disease Renal disease

URATE, HYPERURICEMIA & GOUT Urate: end product of purine metabolism Urate: end product of purine metabolism Hyperuricemia: serum urate > urate solubility (> 6.8 mg/dl) Hyperuricemia: serum urate > urate solubility (> 6.8 mg/dl) Gout: deposition of monosodium urate crystals in tissues Gout: deposition of monosodium urate crystals in tissues

HYPERURICEMIA & GOUT Hyperuricemia caused by Hyperuricemia caused byOverproductionUnderexcretion No Gout w/o crystal deposition No Gout w/o crystal deposition

THE GOUT CASCADE Urate Urate OevrproductionUnderexcretion OevrproductionUnderexcretion Hyperuricemia Hyperuricemia ________________________________________ ________________________________________ SilentGoutRenalAssociated SilentGoutRenalAssociated Tissue manifestationsCV events & Tissue manifestationsCV events & Deposition mortality Deposition mortality

GOUT: A Chronic Disease of 4 stages Asymptomatic hyperuricemia Asymptomatic hyperuricemia Acute Flares of crystallization Acute Flares of crystallization Intervals between flares Intervals between flares Advanced Gout & Complications Advanced Gout & Complications

ACUTE GOUTY FLARES Abrupt onset of severe joint inflammation, often nocturnal; Abrupt onset of severe joint inflammation, often nocturnal; Warmth, swelling, erythema, & pain; Possibly fever Untreated? Resolves in 3-10 days Untreated? Resolves in 3-10 days 90% 1 st attacks are monoarticular 90% 1 st attacks are monoarticular 50% are podagra 50% are podagra

SITES OF ACUTE FLARES 90% of gout patients eventually have podagra : 1st MTP joint 90% of gout patients eventually have podagra : 1st MTP joint

Sites Can occur in other joints, bursa & tendons Can occur in other joints, bursa & tendons

INTERVALS SANS FLARES Asymptomatic Asymptomatic If untreated, may advance If untreated, may advance Intervals may shorten Intervals may shorten Crystals in asx joints Crystals in asx joints Body urate stores increase Body urate stores increase

FLARE INTERVALS Silent tissue deposition & Hidden Damage Silent tissue deposition & Hidden Damage

ADVANCED GOUT Chronic Arthritis Chronic Arthritis X-ray Changes X-ray Changes Tophi Develop Tophi Develop Acute Flares continue Acute Flares continue

ADVANCED GOUT Chronic Arthritis Chronic Arthritis Polyarticular acute flares with upper extremities more involved Polyarticular acute flares with upper extremities more involved

TOPHI Solid urate deposits in tissues Solid urate deposits in tissues

TOPHI Irregular & destructive Irregular & destructive

TOPHI RISK FACTORS Long duration of hyperuricemia Long duration of hyperuricemia Higher serum urate Higher serum urate Long periods of active, untreated gout Long periods of active, untreated gout

RADIOLOGIC SIGNS

X-RAYS

X-RAYS

DIAGNOSING GOUT Hx & P.E. Hx & P.E. Synovial fluid analysis Synovial fluid analysis Not Serum Urate Not Serum Urate

SERUM URATE LEVELS Not reliable Not reliable May be normal with flares May be normal with flares May be high with joint Sx from other causes May be high with joint Sx from other causes

GOUT RISK FACTORS Male Male Postmenopausal female Postmenopausal female Older Older Hypertension Hypertension Pharmaceuticals: Pharmaceuticals: Diuretics, ASA, cyclosporine

GOUT RISK FACTORS Transplant Transplant Alcohol intake Alcohol intake Highest with beer Not increased with wine High BMI (obesity) High BMI (obesity) Diet high in meat & seafood Diet high in meat & seafood

SYNOVIAL FLUID ANALYSIS (Polarized Light Microscopy) The Gold standard The Gold standard Crystals intracellular during attacks Crystals intracellular during attacks Needle & rod shapes Needle & rod shapes Strong negative birefringence Strong negative birefringence

SYNOVIAL FLUID

DIFFERENTIAL DIAGNOSIS Pseudogout: Chondrocalcinosis, CPPD Pseudogout: Chondrocalcinosis, CPPD Psoriatic Arthritis Psoriatic Arthritis Osteoarthritis Osteoarthritis Rheumatoid arthritis Rheumatoid arthritis Septic arthritis Septic arthritis Cellulitis Cellulitis

Gout vs. CPPD Similar Acute attacks Similar Acute attacks Different crystals under Micro; Different crystals under Micro; Rhomboid, irregular in CPPD

Gout vs CPPD

RA vs Gout Both have polyarticular, symmetric arthritis Both have polyarticular, symmetric arthritis Tophi can be mistaken for RA nodules Tophi can be mistaken for RA nodules

RA vs Gout

REDNECK MEDICAL TERMS “BENIGN” : WHAT YOU BE AFTER YOU BE EIGHT “BENIGN” : WHAT YOU BE AFTER YOU BE EIGHT

TREATMENT GOALS Rapidly end acute flares Rapidly end acute flares Protect against future flares Reduce chance of crystal inflammation Prevent disease progression Prevent disease progression Lower serum urate to deplete total body urate pool Correct metabolic cause

ENDING ACUTE FLARES Control inflammation & pain & resolve the flare Control inflammation & pain & resolve the flare Not a cure Not a cure Crystals remain in joints Crystals remain in joints Don’t try to lower serum urate during a flare Don’t try to lower serum urate during a flare Choice of med not as critical as alacrity & duration EBM Choice of med not as critical as alacrity & duration EBM

Acute Flare Med Choices NSAIDS NSAIDS Colchicine Colchicine Corticosteroids Corticosteroids

MED Considerations NSAIDS : NSAIDS : Interaction with warfarin Contraindicated in: Renal disease PUD GI bleeders ASA-induced RAD

MED Considerations Colchicine : Colchicine : Not as effective “late” in flare Drug interaction : Statins, Macrolides, Cyclosporine Contraindicated in dialysis pt.s Cautious use in : renal or liver dysfunction; active infection, age > 70

MED Considerations Corticosteroids : Corticosteroids : Worse glycemic control May need to use mod-high doses

TREATMENT GOALS Rapidly end acute flares Rapidly end acute flares Protect against future flares Reduce chance of crystal inflammation Prevent disease progression Prevent disease progression Lower serum urate to deplete total body urate pool Correct metabolic cause

PROTECTION VS. FUTURE FLARES Colchicine : mg/day Colchicine : mg/day Low-dose NSAIDS Low-dose NSAIDS Both decrease freq & severity of flares Both decrease freq & severity of flares Prevent flares with start of urate-lowering RX Prevent flares with start of urate-lowering RX Best with 6 mos of concommitant RX Best with 6 mos of concommitant RXEBM Won’t stop destructive aspects of gout Won’t stop destructive aspects of gout

TREATMENT GOALS Rapidly end acute flares Rapidly end acute flares Protect against future flares Reduce chance of crystal inflammation Prevent disease progression Prevent disease progression Lower serum urate to deplete total body urate pool Correct metabolic cause

PREVENT DISEASE PROGRESSION Lower urate to < 6 mg/dl : Depletes Lower urate to < 6 mg/dl : Depletes Total body urate pool Deposited crystals EBM RX is lifelong & continuous RX is lifelong & continuous MED choices : MED choices : Uricosuric agents Xanthine oxidase inhibitor

PREVENT THIS

URICOSURIC AGENTS Probenecid, (Losartan & fenofibrate for mild disease) Probenecid, (Losartan & fenofibrate for mild disease) Increased secretion of urate into urine Increased secretion of urate into urine Reverses most common physiologic abnormality in gout ( 90% pt.s are underexcretors) Reverses most common physiologic abnormality in gout ( 90% pt.s are underexcretors)

XANTHINE OXIDASE INHIBITOR Allopurinol : Allopurinol : Blocks conversion of hypoxanthine to uric acid Blocks conversion of hypoxanthine to uric acid Effective in overproducers Effective in overproducers May be effective in underexcretors May be effective in underexcretors Can work in pt.s with renal insufficiency Can work in pt.s with renal insufficiency

WHICH AGENT ? AllopurinolUricosuric Issue in renal disease X X Drug interactions X X Potentially fatal hypersen- sitivity syndrome X sitivity syndrome X Risk of nephrolithiasis X Mutiple daily dosing X

WHICH AGENT Base choice on above considerations & whether pt is an overproducer or underexcretor : Need to get a 24-hr. urine for urate excretion: Base choice on above considerations & whether pt is an overproducer or underexcretor : Need to get a 24-hr. urine for urate excretion: < underexcretor (uricosuric) > overproducer (allopurinol)

NEW AGENTS RX gaps : RX gaps : Can’t always get urate < 6 Can’t always get urate < 6 Allergies Allergies Drug interactions Drug interactions Allopurinol intolerance Allopurinol intolerance Worse Renal disease Worse Renal disease

URICASE ENZYMES (Stay Tuned) Catabolize urate to allantoin: Catabolize urate to allantoin: More soluble, excretable form Currently approved for hypoeruricemia in tumor lysis syndrome Currently approved for hypoeruricemia in tumor lysis syndrome Some concerns: fatal immunogenicity & unknown long-term effects Some concerns: fatal immunogenicity & unknown long-term effects

CASE STUDIES

CASE J.F. CASE J.F. 80 YO W F c/o acute overnight pain & swelling in R knee 80 YO W F c/o acute overnight pain & swelling in R knee PE: 5’1’’ & 180 lbs PE: 5’1’’ & 180 lbs R knee swollen, warm & erythematous PMH : HTN x 5 yrs PMH : HTN x 5 yrs Meds: HCTZ (25 QD) & ASA Meds: HCTZ (25 QD) & ASA SH : 20 PY smoker; 5 wine drinks/wk SH : 20 PY smoker; 5 wine drinks/wk

WHAT ARE J.F.’s RISK FACTORS FOR GOUT ? A. HTN A. HTN B. SMOKER B. SMOKER C. HCTZ C. HCTZ D. ASA D. ASA WINE CONSUMPTION WINE CONSUMPTION OBESITY OBESITY AGE AGE POSTMENOPAUSAL POSTMENOPAUSAL

HOW WOULD YOU DX GOUT ? A. HX & PE COMPATIBLE A. HX & PE COMPATIBLE B. CHECK SERUM URATE LEVEL B. CHECK SERUM URATE LEVEL ASSESS SYNOVIAL FLUID ASSESS SYNOVIAL FLUID TRIAL OF COLCHICINE TRIAL OF COLCHICINE CHECK X-RAYS CHECK X-RAYS

IF YOU DX GOUT, WHAT RX TODAY? (& Why?) A. MOTRIN A. MOTRIN B. INDOCIN B. INDOCIN C. PREDNISONE C. PREDNISONE D. ALLOPURINOL D. ALLOPURINOL E. PROBENECID E. PROBENECID F. COLCHICINE F. COLCHICINE

NEXT STEP FOR J.F. ? A. Modify risk factors A. Modify risk factors B. Give refills to rx next flare B. Give refills to rx next flare C. Start colchicine to prevent flares C. Start colchicine to prevent flares D. Check serum urate level D. Check serum urate level E. Start allopurinol E. Start allopurinol F. Start probenecid F. Start probenecid

CASE M.B. CASE M.B. 56 YO W M c/o hand stiffness & growths 56 YO W M c/o hand stiffness & growths PE : 6’2’’ & 205 lbs PE : 6’2’’ & 205 lbs Multiple tophi; chronic arthritis PMH : DM x 8 yrs; gout x4 yrs, but no flares x 3 yrs, lost 20# on Atkins diet PMH : DM x 8 yrs; gout x4 yrs, but no flares x 3 yrs, lost 20# on Atkins diet Meds: Glyburide; colchicine (0.6 mg TID) Meds: Glyburide; colchicine (0.6 mg TID) Labs: Creat.= 2.0; Urate = 11.4 Labs: Creat.= 2.0; Urate = 11.4

IN WHAT STAGE OF GOUT IS M.B. ? A. Doesn’t have gout A. Doesn’t have gout B. ASX. Hyperuricemia B. ASX. Hyperuricemia C. Interflare period C. Interflare period D. Advanced Gout D. Advanced Gout

WOULD YOU CHANGE MD’S RX ? No – Not gout No – Not gout No – No flare x 3 yrs. No – No flare x 3 yrs. Yes - Increase colchicine Yes - Increase colchicine Yes – Add allopurinol Yes – Add allopurinol Yes – Add benemid Yes – Add benemid

WHAT OTHER ISSUES WOULD YOU CONSIDER ? Renal dysfunction Renal dysfunction Weight Weight DM DM Glyburide Glyburide Diet Diet

CONCLUSIONS Gout is chronic with 4 stages Gout is chronic with 4 stages Uncontrolled gout can lead to severe disease Uncontrolled gout can lead to severe disease Separate RX for flares & preventing advancement Separate RX for flares & preventing advancement Many meds for flares Many meds for flares Treating the disease requires lowering urate Treating the disease requires lowering urate Get a 24-hr urine for urate excretion Get a 24-hr urine for urate excretion

QUESTIONS QUESTIONS